These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3068485)

  • 1. Shiga toxin as inhibitor of protein synthesis.
    Donohue-Rolfe A; Jacewicz M; Keusch GT
    Methods Enzymol; 1988; 165():231-5. PubMed ID: 3068485
    [No Abstract]   [Full Text] [Related]  

  • 2. Shiga toxin attacks bacterial ribosomes as effectively as eucaryotic ribosomes.
    Suh JK; Hovde CJ; Robertus JD
    Biochemistry; 1998 Jun; 37(26):9394-8. PubMed ID: 9649321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of purified Shiga toxin from Shigella dysenteriae 1.
    Yutsudo T; Honda T; Miwatani T; Takeda Y
    Microbiol Immunol; 1986; 30(11):1115-27. PubMed ID: 3100915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vero toxins (Shiga-like toxins) produced by enterohemorrhagic Escherichia coli (verocytotoxin-producing E. coli).
    Takeda Y; Kurazono H; Yamasaki S
    Microbiol Immunol; 1993; 37(8):591-9. PubMed ID: 8246822
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of prokaryotic translation by the Shiga toxin enzymatic subunit.
    Skinner LM; Jackson MP
    Microb Pathog; 1998 Feb; 24(2):117-22. PubMed ID: 9480794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The mechanism of action of Shiga toxin].
    Dubinina EN; Luk'ianov EV; Kozlov IuV; Baev AA
    Dokl Akad Nauk SSSR; 1988; 302(1):226-8. PubMed ID: 3229307
    [No Abstract]   [Full Text] [Related]  

  • 7. Shiga toxin from Shigella dysenteriae 1 inhibits protein synthesis in reticulocyte lysates by inactivation of aminoacyl-tRNA binding.
    Brown JE; Obrig TG; Ussery MA; Moran TP
    Microb Pathog; 1986 Aug; 1(4):325-34. PubMed ID: 3334156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxins that inhibit host protein synthesis.
    Obrig TG
    Methods Enzymol; 1994; 235():647-56. PubMed ID: 8057934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins.
    Endo Y; Tsurugi K; Yutsudo T; Takeda Y; Ogasawara T; Igarashi K
    Eur J Biochem; 1988 Jan; 171(1-2):45-50. PubMed ID: 3276522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shigella toxin inhibition of binding and translation of polyuridylic acid by Escherichia coli ribosomes.
    Olenick JG; Wolfe AD
    J Bacteriol; 1980 Mar; 141(3):1246-50. PubMed ID: 6988411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cytotoxic activity of Shigella toxin. Evidence for catalytic inactivation of the 60 S ribosomal subunit.
    Reisbig R; Olsnes S; Eiklid K
    J Biol Chem; 1981 Aug; 256(16):8739-44. PubMed ID: 6894922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunochemical and cytotoxic activities of Shigella dysenteriae 1 (shiga) and shiga-like toxins.
    O'Brien AD; Laveck GD
    Infect Immun; 1982 Mar; 35(3):1151-4. PubMed ID: 7040247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocytosis from coated pits of Shiga toxin: a glycolipid-binding protein from Shigella dysenteriae 1.
    Sandvig K; Olsnes S; Brown JE; Petersen OW; van Deurs B
    J Cell Biol; 1989 Apr; 108(4):1331-43. PubMed ID: 2564398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of monoclonal antibodies to Shiga toxin.
    Griffin DE; Gentry MK; Brown JE
    Infect Immun; 1983 Jul; 41(1):430-3. PubMed ID: 6345399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional analysis of the Shiga toxin and Shiga-like toxin type II variant binding subunits by using site-directed mutagenesis.
    Jackson MP; Wadolkowski EA; Weinstein DL; Holmes RK; O'Brien AD
    J Bacteriol; 1990 Feb; 172(2):653-8. PubMed ID: 2404947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of the Shiga toxin gene in a chlorate-resistant derivative of Shigella dysenteriae type 1 that retains virulence.
    Neill RJ; Gemski P; Formal SB; Newland JW
    J Infect Dis; 1988 Oct; 158(4):737-41. PubMed ID: 3049838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mode of action of Shiga toxin on peptide elongation of eukaryotic protein synthesis.
    Obrig TG; Moran TP; Brown JE
    Biochem J; 1987 Jun; 244(2):287-94. PubMed ID: 3663122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A monoclonal antibody to Shigella dysenteriae serotype 13 cross-reacting with Shiga toxin.
    Qadri F; Azim T; Hossain A; Islam D; Mondol G; Faruque SM; Albert MJ
    FEMS Microbiol Lett; 1993 Mar; 107(2-3):343-7. PubMed ID: 8472916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification of Shiga toxin by alpha-D-galactose-(1----4)-beta-D-galactose-(1----4)-beta-D-glucose-(1- ---) receptor ligand-based chromatography.
    Ryd M; Alfredsson H; Blomberg L; Andersson A; Lindberg AA
    FEBS Lett; 1989 Dec; 258(2):320-2. PubMed ID: 2689221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Shiga and Shiga-like toxins].
    Ciudin L
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1990; 35(1):1-16. PubMed ID: 2173117
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.